Target $5.17

الموضوع في 'السوق الأمريكي للأوراق الماليه' بواسطة cmkx, بتاريخ ‏4 ابريل 2005.

  1. cmkx

    cmkx عضو جديد

    التسجيل:
    ‏22 فبراير 2005
    المشاركات:
    620
    عدد الإعجابات:
    0
    مكان الإقامة:
    الكويت
    BIPH -- Biophan Technologies, Inc.
    Com ($0.005)

    COMPANY NEWS AND PRESS RELEASES FROM OTHER SOURCES:

    Biophan Technologies, Inc. Rated 'Outperform,' Target $5.17 by Investrend Affiliate Beacon Equity Research

    NEW YORK, Apr 04, 2005 (BUSINESS WIRE) -- (Investrend Research Syndicate) Biophan Technologies, Inc. (OTCBB: BIPH) has been rated "Outperform," with a price target of $5.17 by Investrend Research affiliate Beacon Equity Research. The report is authored by Senior Research Analyst, Shailesh Dhuri.
    The full report is available at http://www.beaconequityresearch.com and http://www.investrendresearch.com

    In the report, Mr. Dhuri writes, "Biophan Technologies, Inc. (OTCBB: BIPH) is an emerging biomedical technology company that provides solutions for making biomedical devices safe for use with the Magnetic Resonance Imaging (MRI) diagnostic procedure. Biophan has strong growth prospects in this growing market as it already has accumulated an impressive portfolio of 114 patents; which include 34 issued, 8 allowed, and 72 applications in process. Biophan's patent portfolio covers areas that include nanotechnology (nanomagnetic particle coatings), radio frequency filters, polymer composites, biothermal batteries, and photonics.

    MRI is considered one of the most important medical diagnostic tools available today... However, a serious drawback to MRI technology is that it cannot be safely used on patients with pacemakers or other biomedical implants. This is due to the fact that these devices (such as pacemakers and cardioverter/defibrillator/pacemakers) are sensitive to a variety of forms of electromagnetic interference (EMI). These devices contain sensing and logic systems that respond to low-level electrical signals that come from the targeted tissue region of the patient.

    Our detailed valuation exercise has led to three different values for the firm, under three market conditions. Under our "Average Conditions" assumptions, we arrive at a target share price of $5.20. Under "Optimistic Conditions," the target share price comes to $13.70. Under "Pessimistic Conditions," the target price works out to $0.80. Overall, by using a weighted-average of the three scenarios, we arrive at a price target of $5.17.

    Beacon Equity Research, LLC is a fee-based, comprehensive investment research firm, focusing primarily on the underserved small-cap sector. All Beacon analysts are seasoned industry professionals and adhere to the CFA Institute's (CFAI) stringent ethics and standards of practice guidelines. Beacon Research does not have any investment banking relationships with any of the companies covered. All analysts are compensated prior to performing their investment research and are not compensated in any way based on the future performance of the equities they follow.

    Both Beacon Equity Research and Investrend subscribe to the "Standards for Independent Research Providers" at http://www.firstresearchconsortium.com. Beacon Research Partners has been compensated $18,000 by Biophan Technologies, Inc. for one year of enrollment in its research program.

    Complete information is available at the company's InvestorPower page at http://www.investrend.com/company/list.asp?sPathParam=yes. Investors are advised to read disclosures carefully before trading in the equities of any enrolled company.

    Anyone interested in receiving alerts regarding Biophan research should email contact@investrend.com with "BIPH" in the subject line.

    SOURCE: Biophan Technologies, Inc.



    CONTACT: Beacon Equity Research
    Jeff Bishop, 972-200-5519
    editor@beaconequityresearch.com
    www.beaconequityresearch.com
    or
    Investrend Research
    R. Hempel, 718-896-5060
    contact@investrend.com
    www.investrendresearch.com
    or
    Biophan Technologies, Inc.
    Michael Weiner, 585-214-2441
    mweiner@biophan.com
    www.biophan.com


    Copyright Business Wire 2005

    -0-

    KEYWORD: United States
    North America
    New York
    INDUSTRY KEYWORD: Health
    Biotechnology
    Medical Devices
    Other Health
     
  2. cmkx

    cmkx عضو جديد

    التسجيل:
    ‏22 فبراير 2005
    المشاركات:
    620
    عدد الإعجابات:
    0
    مكان الإقامة:
    الكويت
    Biph 3.11
    حقق اليوم نسبه ارتفاع 12.68 % وخلونا نشوف لي وين يوصل
     
  3. cmkx

    cmkx عضو جديد

    التسجيل:
    ‏22 فبراير 2005
    المشاركات:
    620
    عدد الإعجابات:
    0
    مكان الإقامة:
    الكويت
    go go go